A two arm phase I dose escalation trial of vinflunine with erlotinib or pemetrexed in refractory solid tumors
Phase of Trial: Phase I
Latest Information Update: 15 May 2012
At a glance
- Drugs Erlotinib; Pemetrexed; Vinflunine
- Indications Solid tumours
- Focus Adverse reactions
- 15 May 2012 Actual patient number is 41 according to ClinicalTrials.gov.
- 15 May 2012 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
- 15 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.